FingerprintDive into the research topics of 'Cetuximab is associated with excessive toxicity when combined with bevacizumab plus mFOLFOX6 in metastatic colorectal carcinoma'. Together they form a unique fingerprint.
- Sort by
Allyson J. Ocean, Blase Polite, Paul Christos, Lisa Horvath, Anne Hamilton, Daniel Matulich, Helen X. Chen, Joseph A. Sparano, Hedy L. Kindler
Research output: Contribution to journal › Article › peer-review